ATLAS / Macro Radar / Reporting / AVBP

ArriVent BioPharma, Inc. (AVBP) reporting calendar

ArriVent BioPharma, Inc. files periodic reports with the SEC as AVBP on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
1 Aug 2026 – 23 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open AVBP market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001104659-26-058650
10-K31 Dec 20255 Mar 202664 days0001104659-26-024127
10-Q30 Sep 202510 Nov 202541 days0001104659-25-108847
10-Q30 Jun 202511 Aug 202542 days0001558370-25-010975
10-Q31 Mar 202512 May 202542 days0001558370-25-007276
10-K31 Dec 20243 Mar 202562 days0001558370-25-001999
10-Q30 Sep 202414 Nov 202445 days0001558370-24-015624
10-Q30 Jun 202414 Aug 202445 days0001558370-24-012236
10-Q31 Mar 20248 May 202438 days0001558370-24-007197
10-K31 Dec 202328 Mar 202488 days0001558370-24-004280

Source: SEC EDGAR company submissions for CIK 0001868279. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.